Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Curis ( (CRIS) ) has issued an update.
On February 3, 2026, Curis, Inc. became subject to a one-year Discretionary Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(A), meaning that any renewed noncompliance with Nasdaq rules during this period could trigger an accelerated delisting process without the usual opportunity to submit a compliance plan or receive an additional cure period. On April 27, 2026, Curis received a Delist Determination Letter after its common stock traded below the $1.00 minimum bid price requirement for 30 consecutive business days, and while the company plans to request a new Nasdaq hearing by May 4, 2026 to stay the scheduled May 6, 2026 delisting and trading suspension, there is no assurance its appeal will succeed, creating heightened uncertainty for shareholders and the company’s market listing.
The most recent analyst rating on (CRIS) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Curis stock, see the CRIS Stock Forecast page.
Spark’s Take on CRIS Stock
According to Spark, TipRanks’ AI Analyst, CRIS is a Neutral.
The score is held down primarily by weak financial performance (persistent operating losses and ongoing cash burn) and bearish technicals (trading below key moving averages with negative MACD). Offsetting factors include constructive clinical/regulatory updates and improved expense discipline from the latest earnings call, while corporate actions add dilution risk despite improved Nasdaq compliance.
To see Spark’s full report on CRIS stock, click here.
More about Curis
Curis, Inc. is a biotechnology company focused on developing and commercializing innovative therapeutics, with its common stock listed on the Nasdaq Capital Market. The company’s market presence and access to capital are closely tied to maintaining compliance with Nasdaq’s listing requirements, including minimum bid price thresholds for its shares.
Average Trading Volume: 419,666
Technical Sentiment Signal: Sell
Current Market Cap: $23.99M
For an in-depth examination of CRIS stock, go to TipRanks’ Overview page.